What is cera vs?

CERA, or continuous erythropoietin receptor activator, is a type of erythropoiesis-stimulating agent (ESA) that is used to treat anemia. It is a synthetic version of erythropoietin that stimulates the production of red blood cells in the body.

VS-4718, on the other hand, is a small molecule inhibitor that targets focal adhesion kinase (FAK), an enzyme that plays a role in the growth and spread of cancer cells. It is being studied as a potential treatment for different types of cancer, including ovarian and non-small cell lung cancer.

While both CERA and VS-4718 are used in the medical field, they are used for different purposes and have different mechanisms of action. CERA stimulates the production of red blood cells, while VS-4718 targets a specific enzyme involved in cancer growth and spread.